X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adult (4) 4
chronic myelogenous leukemia (4) 4
female (4) 4
humans (4) 4
imatinib mesylate (4) 4
index medicus (4) 4
male (4) 4
middle aged (4) 4
aged (3) 3
chronic myeloid leukemia (3) 3
young adult (3) 3
adolescent (2) 2
antineoplastic agents - therapeutic use (2) 2
benzamides (2) 2
cancer (2) 2
care and treatment (2) 2
hematology (2) 2
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (2) 2
leukemia, myeloid, chronic-phase - drug therapy (2) 2
oncology (2) 2
piperazines - therapeutic use (2) 2
prognosis (2) 2
pyrimidines - therapeutic use (2) 2
therapy (2) 2
treatment outcome (2) 2
1st-line imatinib (1) 1
aged, 80 and over (1) 1
allogeneic stem cell transplantation (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
bcr-abl transcripts (1) 1
benzamides - administration & dosage (1) 1
biomarkers, pharmacological - analysis (1) 1
biomarkers, pharmacological - metabolism (1) 1
biomarkers, tumor - analysis (1) 1
biomarkers, tumor - genetics (1) 1
biomarkers, tumor - metabolism (1) 1
bone-marrow angiogenesis (1) 1
chimerism (1) 1
chromosomal abnormality (1) 1
chromosome aberrations (1) 1
chronic disease (1) 1
chronic graft (1) 1
cml (1) 1
cml analysis (1) 1
cohort studies (1) 1
colony-stimulating factor (1) 1
complete molecular remission (1) 1
cytogenetic analysis (1) 1
dasatinib (1) 1
discontinuation (1) 1
donor lymphocyte infusions (1) 1
dynamics (1) 1
evolution (1) 1
genetic aspects (1) 1
genetics & heredity (1) 1
genotype (1) 1
gimema working party (1) 1
hematology, oncology and palliative medicine (1) 1
hematopoietic stem cell transplantation - adverse effects (1) 1
hematopoietic stem cell transplantation - methods (1) 1
hematopoietic suppression (1) 1
host-disease (1) 1
in-vitro (1) 1
insights (1) 1
interferon-alpha (1) 1
interferon-gamma (1) 1
interferon-gamma - genetics (1) 1
interferon-gamma - metabolism (1) 1
jak3 pathway (1) 1
leukemia, myelogenous, chronic, bcr-abl positive - diagnosis (1) 1
leukemia, myelogenous, chronic, bcr-abl positive - genetics (1) 1
leukemia, myeloid, chronic-phase - enzymology (1) 1
leukemia, myeloid, chronic-phase - genetics (1) 1
leukemia, myeloid, chronic-phase - therapy (1) 1
medical colleges (1) 1
medical education (1) 1
mesylate therapy (1) 1
molecular diagnostic techniques (1) 1
multivariate analysis (1) 1
negative cells (1) 1
nilotinib (1) 1
outcomes (1) 1
philadelphia-chromosome (1) 1
piperazines - administration & dosage (1) 1
polymorphism, single nucleotide - physiology (1) 1
positive clone (1) 1
progenitor cells (1) 1
prognostic influence (1) 1
protein kinase inhibitors - therapeutic use (1) 1
pyrimidines - administration & dosage (1) 1
regression analysis (1) 1
responses (1) 1
retrospective studies (1) 1
single-center (1) 1
stem-cells (1) 1
survival analysis (1) 1
transplantation conditioning - adverse effects (1) 1
transplantation conditioning - methods (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 2766 - 2766
Abstract Abstract 2766 Superior efficacy of Bcr-Abl tyrosine kinase inhibitors in chronic myeloid leukemia (CML) therapy has increased the demand for more... 
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 1677 - 1677
Abstract Abstract 1677 Background: BCR-ABL1 kinase domain (KD) point mutation causes resistance to tyrosine kinase inhibitors (TKI) in CML patients through... 
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 2763 - 2763
Abstract Abstract 2763 Approximately 50% of CP CML patients achieve complete molecular response (CMR) at 6–7 years of first-line imatinib therapy. Although... 
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 11/2010, Volume 16, Issue 21, pp. 5339 - 5350
PURPOSE: The present study analyzed treatment outcomes of imatinib therapy by interindividual genetic variants in candidate biological pathways of chronic... 
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 2765 - 2765
Abstract Abstract 2765 In CML, achievement of major molecular response (MMR) is a significant prognostic factor as it has been shown to be associated with... 
Journal Article
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.